Unknown

Dataset Information

0

Vaccine formulations in clinical development for the prevention of severe acute respiratory syndrome coronavirus 2 infection.


ABSTRACT: The COVID-19 pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has led to an unprecedented effort toward the development of an effective and safe vaccine. Aided by extensive research efforts into characterizing and developing countermeasures towards prior coronavirus epidemics, as well as recent developments of diverse vaccine platform technologies, hundreds of vaccine candidates using dozens of delivery vehicles and routes have been proposed and evaluated preclinically. A high demand coupled with massive effort from researchers has led to the advancement of at least 31 candidate vaccines in clinical trials, many using platforms that have never before been approved for use in humans. This review will address the approach and requirements for a successful vaccine against SARS-CoV-2, the background of the myriad of vaccine platforms currently in clinical trials for COVID-19 prevention, and a summary of the present results of those trials. It concludes with a perspective on formulation problems which remain to be addressed in COVID-19 vaccine development and antigens or adjuvants which may be worth further investigation.

SUBMITTER: Batty CJ 

PROVIDER: S-EPMC7733686 | biostudies-literature | 2021 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications

Vaccine formulations in clinical development for the prevention of severe acute respiratory syndrome coronavirus 2 infection.

Batty Cole J CJ   Heise Mark T MT   Bachelder Eric M EM   Ainslie Kristy M KM  

Advanced drug delivery reviews 20201213


The COVID-19 pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has led to an unprecedented effort toward the development of an effective and safe vaccine. Aided by extensive research efforts into characterizing and developing countermeasures towards prior coronavirus epidemics, as well as recent developments of diverse vaccine platform technologies, hundreds of vaccine candidates using dozens of delivery vehicles and routes have been proposed and evaluated preclinic  ...[more]

Similar Datasets

| S-EPMC8406869 | biostudies-literature
| S-EPMC3035556 | biostudies-literature
| S-EPMC521834 | biostudies-other
| S-EPMC7665603 | biostudies-literature
| S-EPMC7985679 | biostudies-literature
2022-03-01 | GSE193555 | GEO
| S-EPMC8021130 | biostudies-literature
| S-EPMC9389018 | biostudies-literature
| S-EPMC9047227 | biostudies-literature
| S-EPMC5450662 | biostudies-literature